# US 2019/0376125 A1 · Methods for detecting multiple nucleic acids in a sample using reporter compounds and binding members thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0376125 A1
- Document ID: US20190376125A1
- Status: Published application
- Kind: A1
- Application number: 16/371,268
- Filed: 2019-04-01
- Published: 2019-12-12
- Earliest claimed: 2014-02-21
- Assignees: Alere Technologies GmbH
- Applicants: Alere Technologies GmbH
- Inventors: Thomas Ullrich
- Web page: https://patentgrep.com/patent/US20190376125A1

## CPC

- C12Q 1/6818: involving interaction of two or more labels, e.g. resonant energy transfer
- B01L 3/502715: {characterised by interfacing components, e.g. fluidic, electrical, optical or mechanical interfaces}
- C12Q 1/6844: Nucleic acid amplification reactions
- G01N 33/52: Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper {and including single- and multilayer analytical elements (immunological elements G01N33/54386; involving labelled immunochemicals G01N33/58; for haemoglobin or occult blood G01N33/72)}
- G01N 33/542: with steric inhibition or signal modification, e.g. fluorescent quenching
- B01L 2300/0819: Microarrays; Biochips
- B01L 2400/0481: squeezing of channels or chambers
- G01N 21/645: {Specially adapted constructive features of fluorimeters}
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- B01L: CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

The present invention relates to methods for determining the presence and/or amount of multiple nucleic acids in a sample.

## Claims

### Claim at position 1

1-35. (canceled)

### Claim 36

A method of determining the presence and/or amount of nucleic acids in a sample, comprising
(a) providing
an amount of a first nucleic acid;
an amount of a second nucleic acid;
an amount of a FRET compound capable of forming complexes with the first nucleic acid, wherein the FRET compound comprises a binding portion specific to a region of the first nucleic acid and a first detectable label that has, in an uncomplexed state, a first detectable characteristic and, in a complexed state, a second detectable characteristic that differs from the first detectable characteristic;
an amount of a reporter compound capable of forming complexes with the second nucleic acid, wherein each reporter compound comprises a binding portion specific to a region of the second nucleic acid and a second detectable label; and
a binding member capable of capturing the reporter compound, wherein forming of complexes of the second nucleic acid with the reporter compound inhibits capturing of the reporter compound by the binding member;
(b) subjecting the first and/or second nucleic acid to amplification;
(c) forming complexes each comprising a first nucleic acid and a FRET compound;
(d) forming complexes of a subset of the amount of reporter compound with a second nucleic acid;
(e) capturing a remaining subset of the amount of reporter compound not in complex with a second nucleic acid on the binding member;
(f) determining a value indicative for the presence and/or amount of first nucleic acid captured by FRET compounds; and
(g) determining a value indicative for the presence and/or amount of reporter compound captured on the binding member.

### Claim 37 (depends on 36)

The method of claim 36, further comprising determining a value indicative for the presence and/or amount of second nucleic acid based on the value indicative for the presence and/or amount of reporter compound captured on the binding member.

### Claim 38 (depends on 36)

The method of claim 36, wherein the first detectable label or second detectable label is a fluorescent label.

### Claim 39 (depends on 38)

The method of claim 38, wherein the fluorescent label emits in a wavelength range of from 300 nm to 850 nm.

### Claim 40 (depends on 36)

The method of claim 36, wherein the value indicative for the presence and/or amount of first nucleic acid captured by FRET compounds is determined in a complexed state of the FRET compounds.

### Claim 41 (depends on 36)

The method of claim 36, wherein the first nucleic acid is an analyte.

### Claim 42 (depends on 36)

The method of claim 36, wherein the second nucleic acid is selected from the group consisting of a second analyte and a control nucleic acid.

### Claim 43 (depends on 36)

The method of claim 36, wherein the steps of (i) forming complexes each comprising a first nucleic acid and a FRET compound, (ii) forming complexes of a subset of the amount of reporter compound with at least a subset of the amount of second nucleic acid, and (iii) capturing a remaining subset of the amount of reporter compound not in complex with a second nucleic acid on the binding member are performed concomitantly.

### Claim 44 (depends on 36)

The method of claim 36, wherein amplification of the first and second nucleic acid is initiated prior to the step of forming complexes of a subset of the amount of reporter compound with at least a subset of the amount of second nucleic acid.

### Claim 45 (depends on 44)

The method of claim 44, wherein the second nucleic acid is selected from the group consisting of a positive amplification control and a negative amplification control.

### Claim 46 (depends on 36)

The method of claim 36, wherein the binding member comprises one or more different reporter specific capture compounds being capable of capturing a reporter compound on the binding member.

### Claim 47 (depends on 46)

The method of claim 46, wherein the reporter specific capture compounds are oligonucleotides.

### Claim 48 (depends on 46)

The method of claim 46, wherein the different reporter specific capture compounds are arranged on different locations with respect to the binding member.

### Claim 49 (depends on 46)

The method of claim 46, wherein the reporter compounds are captured on the binding member by forming complexes with the reporter specific capture compounds.

### Claim 50 (depends on 46)

The method of claim 46, wherein at least a part of an interaction site of the reporter compound being capable of forming a complex with a second nucleic acid is also capable of forming a complex with a reporter specific capture compound.

### Claim 51 (depends on 46)

The method of claim 46, wherein the reporter specific capture compounds and the second nucleic acid compete for forming a complex with the reporter compound.

### Claim 52 (depends on 36)

The method of claim 36, further comprising subjecting the first and/or second nucleic acids to reverse transcription prior to subjecting them to amplification.

### Claim 53 (depends on 44)

The method of claim 44, wherein the amplification is an isothermal amplification method.

### Claim 54 (depends on 36)

The method of claim 36, wherein the first detectable characteristic is a state where emission of a chromophore is present.

### Claim 55 (depends on 36)

The method of claim 36, the second detectable characteristic is a state where emission of the chromophore is quenched.
